This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Study of the Pancreatic Secretion in Patients with Thrombophlebitis

DAVID A. DREILING, M.D.; LESTER BLUM, M.D.; MARTIN SANDERS, M.D.

AMA Arch Intern Med. 1955;96(4):490-495.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The association of pancreatic cancer and recurring thrombophlebitis was first recorded by Trousseau.¹ In 1934, Sproul,² from a careful and extensive study of postmortem material, stressed the unusually high frequency of thrombophlebitis in malignant diseases of the body and tail of the pancreas. This finding has been corroborated by the investigations of Kenny³ and others,* but the pathogenesis of the relationship has remained obscure. The most commonly suggested etiological mechanism has related the thrombophlebitis to alterations in blood coagulation.

Changes in the blood coagulation mechanism have been noted by many observers, usually in connection with studies of experimental and clinical pancreatitis. Blood coagulation alterations have also been recorded in patients with pancreatic cancer and have been stressed recently by Shingleton⁸ and Innerfield,⁹ who introduced laboratory diagnostic procedures based upon them. Shingleton, using his paritol blood coagulation test technique, noted that an increased blood clotting reaction . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Departments of Surgery and Hematology, the Mount Sinai Hospital; Assistant Attending Surgeon (Dr. Dreiling), Associate Attending Surgeon (Dr. Blum), and Resident in Hematology (Dr. Sanders).

Footnotes
Submitted for publication June 7, 1955.

The Secretin used in this study was donated by Dr. James B. Hammond, of Eli Lilly & Company, Indianapolis.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?